Modus Therapeutics participates in Aktier Live Sessions
Stockholm, Tuesday, December 14, 2021. Modus Therapeutics Holding AB ("Modus") announces that the company participates in today’s Aktier Live Sessions at 18:00.Modus' CEO John Öhd and CFO Claes Lindblad will be interviewed by Aktier Live Sessions Jonathan Furelid on Tuesday, December 14 at 18:00. The interview is streamed live with the opportunity to ask questions to the company directly in the chat. The company tells of an eventful year during which, among other things, the company was listed on the Nasdaq First North Growth market and started the first clinical study in the planned sepsis